Tower Research Capital (TRC)’s MBody AI Ltd. Ordinary Share MBAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4
Closed -$32 5717
2024
Q3
$32 Buy
+4
New +$52 ﹤0.01% 5583
2023
Q4
Sell
-7
Closed -$217 5940
2023
Q3
$217 Buy
+7
New +$158 ﹤0.01% 5649
2023
Q2
Sell
-463
Closed -$5K 6062
2023
Q1
$5K Sell
463
-453
-49% -$9.49K ﹤0.01% 4941
2022
Q4
$14K Buy
+916
New +$26.9K ﹤0.01% 3494
2021
Q3
Sell
-3
Closed -$1K 5797
2021
Q2
$1K Sell
3
-13
-81% -$2.85K ﹤0.01% 5183
2021
Q1
$4K Buy
+16
New +$3.83K ﹤0.01% 4760
2019
Q3
Sell
-11
Closed -$3K 4117
2019
Q2
$3K Buy
+11
New +$3.76K ﹤0.01% 3120
2017
Q2
Hold
0
2766
2017
Q1
Hold
0
3131
2016
Q4
Hold
0
-$1K 3853
2016
Q3
Sell
-1
Closed -$3.02K 3266
2016
Q2
$1K Buy
+1
New +$3.43K ﹤0.01% 4127
2016
Q1
Hold
0
4180
2015
Q4
Sell
-1
Closed -$4.2K 4520
2015
Q3
$3K Sell
1
-1
-50% -$5.31K ﹤0.01% 3102
2015
Q2
$9K Buy
2
+1
+100% +$7.31K ﹤0.01% 2783
2015
Q1
$6K Buy
+1
New +$9.51K ﹤0.01% 3133

Other funds holding MBAI

Tower Research Capital (TRC)'s MBAI Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of MBody AI Ltd. Ordinary Share (MBAI) in Q4 2024, closing a stake of 4 shares — an estimated $32 sold.

Tower Research Capital (TRC) first reported a position in MBAI in Q1 2015 and held it in 11 quarters. The position peaked at $14K in Q4 2022. 15 funds tracked by Wall St. Rank hold MBAI as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining MBody AI Ltd. Ordinary Share position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4 MBody AI Ltd. Ordinary Share shares in Q4 2024, an estimated $32.
  • Tower Research Capital (TRC) first reported a position in MBody AI Ltd. Ordinary Share in Q1 2015 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s MBody AI Ltd. Ordinary Share position peaked at $14K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held MBody AI Ltd. Ordinary Share as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.